細胞単離/細胞分離市場：製品（消耗品、器具）、細胞タイプ（ヒト細胞、動物細胞）、細胞源（骨髄、脂肪組織）、技術（遠心分離ベース）、用途、エンドユーザー（製薬）-2028年までの世界予測

Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028

細胞分離の世界市場規模は、2023年の44億米ドルから2028年には82億米ドルに達すると予測され、予測期間中のCAGRは13.4%に達するとされています。細胞ベースの研究に対する資金提供の増加などの要因が、市場の成長... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年5月19日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	309	458	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

細胞分離の世界市場規模は、2023年の44億米ドルから2028年には82億米ドルに達すると予測され、予測期間中のCAGRは13.4%に達するとされています。細胞ベースの研究に対する資金提供の増加などの要因が、市場の成長をより速いペースで促進しています。慢性疾患や感染症の発生率は上昇傾向にあり、細胞分離技術を必要とする細胞ベースの治療法などの新しい治療法への需要を促進しています。マイクロ流体ベースのセルソーティング、磁気活性化セルソーティング、蛍光活性化セルソーティングなど、新しく高度な細胞分離技術の開発が、市場の成長を促進しています。政府や民間団体がライフサイエンスやバイオテクノロジーの研究に多額の投資を行っており、それが細胞分離製品・技術の需要を促進している。

"消耗品セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長しそうです。"
製品別では、細胞分離市場は消耗品と機器に区分されます。消耗品セグメントは、予測期間中に最も高いCAGRで成長すると予測されています。この成長は、細胞ベースの研究における消耗品の需要増に起因しています。これは、セグメントの成長に好影響を与えると思われます。消耗品は、手作業による細胞分離手順の必要性を減らすことで、時間を節約することができます。これは、臨床現場など、時間が非常に重要なアプリケーションで特に重要です。様々な実験条件や細胞種に対応できるため、研究者のニーズに合わせてプロトコルをカスタマイズすることができる。消耗品は、分離プロセスにおけるコンタミネーションのリスクを低減することができ、分離された細胞の完全性を維持するために重要である。消耗品は、遺伝子発現解析やプロテオミクスなど、さまざまなダウンストリームアプリケーションに適合するように設計されていることが多い。

"2023年はヒト細胞分野が圧倒的なシェアを占めると予想される"
細胞タイプに基づき、市場はヒト細胞、動物細胞に区分されます。ヒト細胞に関する研究への投資が増加していることから、予測期間中、ヒト細胞セグメントが圧倒的なシェアを占めると予想されます。HeLa細胞などのヒト細胞株は、数十年にわたって研究に使用されており、医学研究の多くの分野で重要なツールとなっています。確立された細胞株があることで、研究者はヒトの細胞を入手し、研究することが容易になりました。研究においてヒト細胞を使用することで、ヒトの生理や病気をより正確に表現することができるため、研究室から臨床への研究成果の伝達を促進することができます。研究においてヒト細胞を使用することは、動物細胞を使用するよりも一般的に受け入れられやすい。なぜなら、ヒト細胞はより関連性が高く、論争も少ないと考えられるからである。

"骨髄細胞分離セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長すると思われる。"
細胞源に基づいて、細胞分離市場は脂肪組織、骨髄、臍帯血/胚性幹細胞、およびその他の細胞源に区分されます。骨髄セグメントは、予測期間中に最も高いCAGRで成長すると予測されています。骨髄には、造血幹細胞、間葉系幹細胞、免疫細胞など、多様な細胞集団が存在するため、様々な治療用途で骨髄由来の幹細胞ベースの製品が商業化されていることが成長の要因である。これらの細胞は単離され、研究、創薬、細胞ベースの治療など、幅広い用途に使用することができる。骨髄細胞の分離は、長年にわたり確立され、標準化されてきたため、研究者は高品質の細胞を容易に入手することができるようになりました。

"表面マーカーベースの細胞分離セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長すると思われます。"
技術に基づいて、細胞分離市場は、遠心分離ベースの細胞分離、表面マーカーベースの細胞分離、およびろ過ベースの細胞分離に分割されます。表面マーカーベースの分離分野は、予測期間中、最も高いCAGRで成長すると予測されています。この成長は、製薬業界におけるこの技術の需要の増加に起因しています。これは、セグメント別の成長を促進する可能性が高い。

"2022年、生体分子分離セグメントが圧倒的なシェアを占めた"
細胞分離市場は、用途に基づき、生体分子分離、幹細胞研究、がん研究、体外診断、組織再生・再生医療、その他の用途に分類されます。細胞分離市場では、生体分子分離分野が圧倒的なシェアを占めています。市場成長を予測する技術的進歩。

"製薬＆バイオテクノロジー企業セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長しそうです。"
エンドユーザーに基づき、細胞分離市場は、製薬＆バイオテクノロジー企業、学術・研究機関、病院・診断ラボ、その他のエンドユーザーに区分されます。予測期間中に最も高いCAGRで成長するのは、製薬・バイオテクノロジー企業セグメントです。製薬・バイオ企業が研究開発活動に注力していることが、市場成長を予測する主な要因の1つとなっています。

「アジア太平洋地域は、より速いペースで成長すると思われる。
細胞分離市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられます。2022年、北米は細胞分離市場の圧倒的なシェアを占めています。同地域の優位性は、同地域における支配的かつ主要な市場プレイヤーの存在、技術的進歩など、さまざまな要因に起因しています。アジア太平洋地域は、人口の増加や医療施設のインフラ整備のための政府の取り組みなど、さまざまな要因によって、より速いペースで成長すると考えられます。
本レポートのために実施した一次インタビューは、以下のように分類されます：

- 回答者別回答者別：供給側-80％、需要側-20
- 回答者別（供給側）：供給側80％、需要側20マネージャー35％、CXO＆ディレクター20％、エグゼクティブ45％。
- 地域別北米：25％、欧州：30％、アジア太平洋：30％、中南米：10％、中近東・アフリカ：5％。
レポート掲載企業一覧
- ダナハーコーポレーション（米国）
- Merck KGaA (ドイツ)
- サーモフィッシャーサイエンティフィック社（米国）
- ベクトン・ディッキンソン・アンド・カンパニー（米国）
- テルモ株式会社（日本）
- アジレント・テクノロジー（米国）
- バイオ・ラッド・ラボラトリーズ・インク（米国）
- コーニング・インコーポレイテッド（米国）
- F.ホフマン・ラ・ロシュ社（スイス(スイス)
- ミルテニ・バイオテック（ドイツ）
- STEMCELL Technologies（カナダ）
- Alfa Laval（スウェーデン）
- Sartorius AG（ドイツ）
- アカデウムライフサイエンス（米国）
- バイオテクネ（米国）
- パーキンエルマー社（米国）
- インベントバイオテクノロジーズ社（米国）
- タカラバイオ株式会社（日本）
- MiCareo Inc.（米国）
- Proteintech Group, Inc.（米国）
- QIAGEN (ドイツ)
- ロンザ社（スイス）
- プロメガ・コーポレーション（米国）
- プルリセレクトライフサイエンス UG (Haftungsbeschränkt) & Co.KG (ドイツ)
- マグバイオ・ジェノミクス（米国）
調査範囲です：
本レポートは、細胞分離市場の詳細な情報を提供します。製品、細胞タイプ、細胞源、技術、用途、エンドユーザー、地域などの異なるセグメントにおける市場規模や今後の成長性を推定することを目的としています。また、主要な市場プレイヤーの会社概要、最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。

レポート購入の主なメリット
本レポートは、シングルユースバイオリアクター市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てることができるようになるでしょう。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、トレンド、機会に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- 細胞分離市場の成長に影響を与える主要な促進要因（細胞ベースの研究に対する政府資金の増加、癌や感染症に苦しむ患者の増加、技術の進歩）、抑制要因（胚性幹細胞の分離に関する倫理的・安全的問題、細胞ベースの研究の高コスト）、機会（新興市場における成長機会）、課題（細胞療法の開発における障害）についての分析。
- 製品開発/イノベーション：新発売の製品に関する詳細なインサイト、細胞分離市場の技術的評価。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域の細胞分離市場を分析しています。
- 市場の多様化：新製品、未開拓の地域、最近の開発、細胞分離市場への投資に関する詳細な情報を提供します。
- 競争力のある評価：細胞分離市場の主要企業の市場シェア、成長戦略、製品提供について詳細に評価します。また、シングルユースバイオリアクター市場の鼓動を理解し、市場動向とともに主要な市場促進要因、阻害要因、課題、機会に関する情報を提供することで、ステークホルダーを支援します。

ページTOPに戻る

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
FIGURE 1 CELL ISOLATION MARKET SEGMENTATION 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 34
1.7.1 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY RESEARCH 37
2.1.2 PRIMARY RESEARCH 37
FIGURE 3 CELL ISOLATION MARKET: PRIMARY RESPONDENTS 38
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 39
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 40
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (TOP-DOWN-BASED ESTIMATION), 2022 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 41
FIGURE 7 INSIGHTS ON CELL ISOLATION MARKET FROM PRIMARY EXPERTS 41
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 8 CELL ISOLATION MARKET: CAGR PROJECTIONS, 2023–2028 43
FIGURE 9 CELL ISOLATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 44
2.4 DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 46
3 EXECUTIVE SUMMARY 48
FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 50
FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 51
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET 52
4 PREMIUM INSIGHTS 53
4.1 CELL ISOLATION MARKET OVERVIEW 53
FIGURE 18 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE GROWTH 53
4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY (2022) 54
FIGURE 19 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 54
4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION, 2023 VS. 2028 54
FIGURE 20 BIOMOLECULE ISOLATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 54
4.4 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 22 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS 57
5.2.1 DRIVERS 57
5.2.1.1 Increasing government funding for cell-based research 57
TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2022 (USD MILLION) 57
5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases 58
TABLE 4 INCIDENCE OF CANCER, BY REGION, 2020 58
TABLE 5 IMPORTANT STATISTICS ON INFECTIOUS DISEASES 59
5.2.1.3 Technological advancements 59
5.2.1.4 Growing focus on personalized medicine 59
TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2021 60
5.2.2 RESTRAINTS 60
5.2.2.1 Ethical & safety issues related to embryonic stem cell isolation 60
5.2.2.2 High cost of cell-based research 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth opportunities in emerging markets 61
5.2.4 CHALLENGES 61
5.2.4.1 Obstacles to developing cell therapies 61
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 62
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS 62
5.4 PRICING ANALYSIS 62
TABLE 7 PRICE OF KEY CELL ISOLATION PRODUCTS OF KEY COMPANIES (2022) 62
5.5 VALUE CHAIN ANALYSIS 63
FIGURE 24 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS 64
5.6 ECOSYSTEM ANALYSIS 64
TABLE 8 CELL ISOLATION MARKET ECOSYSTEM 65
5.7 REGULATORY ANALYSIS 65
5.8 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 9 CELL ISOLATION/ CELL SEPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.8.1 THREAT FROM NEW ENTRANTS 66
5.8.2 THREAT FROM SUBSTITUTES 67
5.8.3 BARGAINING POWER OF SUPPLIERS 67
5.8.4 BARGAINING POWER OF BUYERS 67
5.8.5 DEGREE OF COMPETITION 67
5.9 KEY CONFERENCES & EVENTS IN 2023–2024 67
TABLE 10 CELL ISOLATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS 67
5.10 TECHNOLOGY ANALYSIS 68
5.10.1 MICROFLUIDICS 68
5.10.2 MAGNETIC CELL ISOLATION 68
5.10.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS) 68
5.10.4 ACOUSTIC CELL ISOLATION 69
5.10.5 ACOUSTO-FLUIDIC CELL ISOLATION 69
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 69
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL ISOLATION PRODUCTS 69
FIGURE 26 KEY BUYING CRITERIA FOR CELL ISOLATION PRODUCTS 70
5.12 TRADE ANALYSIS 71
TABLE 11 EXPORT DATA (TOP 10 COUNTRIES) 71
TABLE 12 IMPORT DATA (TOP 10 COUNTRIES) 71
5.13 PATENT ANALYSIS 72
FIGURE 27 PATENT APPLICATIONS RELATED TO CELL ISOLATION, JANUARY 2012–MARCH 2023 72
TABLE 13 LIST OF PATENTS IN CELL ISOLATION MARKET 72
6 CELL ISOLATION MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 14 CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 74
6.2 CONSUMABLES 74
TABLE 15 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 16 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 17 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 18 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 19 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 20 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 76
6.2.1 REAGENTS, KITS, MEDIA, AND SERA 77
6.2.1.1 Disposable nature of reagents and assay kits to drive consistent usage and frequent purchases 77
TABLE 21 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 22 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 23 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 24 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 25 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.2.2 BEADS 79
TABLE 26 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 27 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 28 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 29 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 30 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 31 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 81
6.2.2.1 Magnetic beads 81
6.2.2.1.1 Growing demand for magnetic beads in T-cell and stem cell isolation to drive growth 81
TABLE 32 CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 33 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 34 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 35 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 36 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.2.2.2 Fluorescent beads 83
6.2.2.2.1 Advantages of fluorescent beads to boost adoption 83
TABLE 37 CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 38 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 39 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 40 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 41 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.2.3 DISPOSABLES 85
6.2.3.1 Growing government investments in research to boost growth 85
TABLE 42 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 43 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 44 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 45 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 46 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3 INSTRUMENTS 87
TABLE 47 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 48 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 49 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 50 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 51 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 52 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
6.3.1 CENTRIFUGES 89
6.3.1.1 Growing use of centrifuges in pharma-biotech industry to boost market 89
TABLE 53 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 54 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 55 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 56 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 57 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.3.2 CELL SORTERS 91
6.3.2.1 Launch of innovative and cost-effective cell sorters to support market 91
TABLE 58 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 59 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 60 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 61 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 62 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 93
6.3.3.1 Growing focus on personalized medicine to drive segmental growth 93
TABLE 63 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 64 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 65 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 66 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 67 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.3.4 FILTRATION SYSTEMS 95
6.3.4.1 Increasing research activities in cell biology to boost market 95
TABLE 68 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 69 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 70 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 71 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 72 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 97
7 CELL ISOLATION MARKET, BY CELL TYPE 98
7.1 INTRODUCTION 99
TABLE 73 CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 99
7.2 HUMAN CELLS 99
TABLE 74 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 75 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 76 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 77 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 78 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 79 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
7.2.1 DIFFERENTIATED CELLS 102
7.2.1.1 Growing investments by market players to develop new and innovative products to support growth 102
TABLE 80 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 82 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 104
7.2.2 STEM CELLS 104
7.2.2.1 Rising government initiatives focused on supporting stem cell research to drive market 104
TABLE 85 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 86 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 87 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 88 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 89 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
7.3 ANIMAL CELLS 106
7.3.1 INCREASING INVESTMENTS IN BIOPHARMACEUTICAL R&D FOR VACCINE AND DRUG DEVELOPMENT TO BOOST MARKET 106
TABLE 90 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 91 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 92 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 93 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 94 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 108
8 CELL ISOLATION MARKET, BY CELL SOURCE 109
8.1 INTRODUCTION 110
TABLE 95 CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 110
8.2 BONE MARROW 110
8.2.1 GROWING NUMBER OF COMMERCIALIZED BONE MARROW-DERIVED STEM CELLS TO DRIVE MARKET 110
TABLE 96 CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 97 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 98 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 99 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 100 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.3 ADIPOSE TISSUE 112
8.3.1 ABILITY OF ADIPOSE STEM/STROMAL CELLS TO GENERATE VARIETY OF OTHER CELL TYPES TO DRIVE DEMAND 112
TABLE 101 CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 103 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 114
8.4 CORD BLOOD/EMBRYONIC STEM CELLS 114
8.4.1 HIGH THERAPEUTIC POTENCY OF CORD BLOOD/EMBRYONIC STEM CELLS TO SUPPORT MARKET 114
TABLE 106 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 107 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 108 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 109 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 110 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 116
8.5 OTHER CELL SOURCES 116
TABLE 111 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 112 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 113 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 114 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 115 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 118
9 CELL ISOLATION MARKET, BY TECHNIQUE 119
9.1 INTRODUCTION 120
TABLE 116 CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 120
9.2 CENTRIFUGATION-BASED CELL ISOLATION 120
9.2.1 COST-EFFECTIVENESS OF TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS TO DRIVE MARKET 120
TABLE 117 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 118 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 119 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 120 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 121 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.3 SURFACE MARKER-BASED CELL ISOLATION 122
9.3.1 WIDE USAGE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES TO SUPPORT GROWTH 122
TABLE 122 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 123 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 124 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 125 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 126 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
9.4 FILTRATION-BASED CELL ISOLATION 125
9.4.1 LOW COST OF FILTRATION TECHNIQUE TO BOOST ADOPTION 125
TABLE 127 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 128 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 129 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 130 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 131 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
10 CELL ISOLATION MARKET, BY APPLICATION 127
10.1 INTRODUCTION 128
TABLE 132 CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
10.2 BIOMOLECULE ISOLATION 128
10.2.1 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE CELL ISOLATION MARKET DURING FORECAST PERIOD 128
TABLE 133 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 134 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 135 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 136 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 137 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
10.3 CANCER RESEARCH 130
10.3.1 HIGH DISEASE INCIDENCE TO FUEL DEMAND FOR ADVANCED TREATMENTS 130
TABLE 138 CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 139 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 140 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 141 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 142 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
10.4 STEM CELL RESEARCH 133
10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH 133
TABLE 143 CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 144 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 145 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 146 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 147 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 135
10.5.1 GROWING REGENERATIVE MEDICINE INITIATIVES TO SUPPORT MARKET 135
TABLE 148 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 149 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 150 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 151 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 152 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
10.6 IN VITRO DIAGNOSTICS 137
10.6.1 RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS 137
TABLE 153 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 155 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 139
10.7 OTHER APPLICATIONS 140
TABLE 158 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 159 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 160 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 161 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 162 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
11 CELL ISOLATION MARKET, BY END USER 142
11.1 INTRODUCTION 143
TABLE 163 CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 143
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 143
11.2.1 FAVORABLE R&D INVESTMENTS TO BOOST MARKET GROWTH 143
TABLE 164 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 166 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 145
11.3 ACADEMIC & RESEARCH INSTITUTES 145
11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 145
TABLE 169 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 170 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 171 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 172 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 173 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 148
11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES TO CONTRIBUTE TO MARKET GROWTH 148
TABLE 174 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 175 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 176 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 177 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 178 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
11.5 OTHER END USERS 150
TABLE 179 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 180 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 181 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 182 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 183 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
12 CELL ISOLATION MARKET, BY REGION 152
12.1 INTRODUCTION 153
TABLE 184 CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 153
12.2 NORTH AMERICA 153
FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT 154
TABLE 185 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 186 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 187 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 188 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 189 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 156
TABLE 190 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 156
TABLE 192 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 157
TABLE 193 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 194 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 158
12.2.1 US 158
12.2.1.1 US to dominate North American cell isolation market during forecast period 158
TABLE 195 US: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 196 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 197 US: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 198 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 199 US: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 160
TABLE 200 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 201 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 161
TABLE 202 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 161
TABLE 203 US: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 204 US: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 162
12.2.2 CANADA 162
12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada 162
TABLE 205 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 206 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 207 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 208 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 209 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 164
TABLE 210 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 211 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 165
TABLE 212 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 165
TABLE 213 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 214 CANADA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 166
12.2.3 NORTH AMERICA: RECESSION IMPACT 166
12.3 EUROPE 167
TABLE 215 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 216 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 167
TABLE 217 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 218 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 219 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 220 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 169
TABLE 221 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 222 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 169
TABLE 223 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 170
TABLE 224 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 225 EUROPE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 170
12.3.1 GERMANY 171
12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe 171
TABLE 226 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 227 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 228 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 229 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 230 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 172
TABLE 231 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 232 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 173
TABLE 233 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 173
TABLE 234 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 235 GERMANY: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174

ページTOPに戻る

Table of Contents

Summary

The global cell isolation market size is projected to reach USD 8.2 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as increasing funding for cell-based research, are driving the market growth at a faster pace. The incidence of chronic and infectious diseases is on the rise, which is driving the demand for new therapies, including cell-based therapies that require cell isolation technologies. The development of new and advanced cell isolation technologies, such as microfluidics-based cell sorting, magnetic-activated cell sorting, and fluorescence-activated cell sorting, is driving the growth of the market. Governments and private organizations are investing heavily in life sciences and biotechnology research, which is driving the demand for cell isolation products and technologies.

“The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of product, the cell isolation market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. This is likely to have a positive impact on segmental growth. Consumables can save time by reducing the need for manual cell isolation procedures. This can be especially important for applications where time is critical, such as in clinical settings. Consumables can be adapted to different experimental conditions and cell types, allowing researchers to customize their protocols to their specific needs. Consumables can reduce the risk of contamination during the isolation process, which is important for maintaining the integrity of the isolated cells. Consumables are often designed to be compatible with a range of downstream applications, such as gene expression analysis and proteomics.

“The human cells segment is expected to hold a dominant share in 2023.”
Based on the cell type, the market is segmented into human cells, and animal cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing investments for the research on human cells. Human cell lines, such as HeLa cells, have been used in research for decades and have become an important tool in many areas of medical research. The availability of established cell lines makes it easier for researchers to obtain and study human cells. The use of human cells in research can facilitate the translation of findings from the laboratory to the clinic, as human cells provide a more accurate representation of human physiology and disease. The use of human cells in research is generally more accepted by the public than the use of animal cells, as human cells are seen as more relevant and less controversial.

“The bone marrow cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of cell source, the cell isolation market is segmented into adipose tissue, bone marrow, and cord blood/embryonic stem cells, and other cell sources. The bone marrow segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications.Bone marrow contains a diverse population of cells, including hematopoietic stem cells, mesenchymal stem cells, and immune cells. These cells can be isolated and used in a wide range of applications, including research, drug discovery, and cell-based therapies. The isolation of bone marrow cells has been well-established and standardized over the years, making it easier for researchers to obtain high-quality cells.

“The surface-marker based cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface-marker based cell isolation, and filtration-based cell isolation. The surface-marker based isolation segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of this technique in the pharmaceutical industries. This is likely to propel segmental growth.

“In 2022, the biomolecule isolation segment held a dominant share.”
Based on application, the cell isolation market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment held a dominant share of the cell isolation market. Technological advancements to project the market growth.

“The pharmaceutical & biotechnology companies segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
Based on end user, the cell isolation market is segmented into pharmaceutical & biotechnology companies, academic and research institutes, hospitals and diagnostic laboratories, and other end users. The pharmaceutical & biotechnology companies segment to grow at the highest CAGR during the forecast period. Pharmaceutical and biotechnology companies’ focus on R&D activities is one of the major factors anticipated to project market growth.

“Asia Pacific region is likely to grow at faster pace.”
The cell isolation market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of cell isolation market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%, and Demand Side - 20%
• By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
• By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Thermo Fisher Scientific, Inc. (US)
• Becton, Dickinson and Company (US)
• Terumo Corporation (Japan)
• Agilent Technologies, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Corning Incorporated (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Miltenyi Biotec (Germany)
• STEMCELL Technologies (Canada)
• Alfa Laval (Sweden)
• Sartorius AG (Germany)
• Akadeum Life Sciences (US)
• Bio-Techne (US)
• PerkinElmer Inc. (US)
• Invent Biotechnologies, Inc. (US)
• Takara Bio, Inc. (Japan)
• MiCareo Inc. (US)
• Proteintech Group, Inc. (US)
• QIAGEN (Germany)
• Lonza (Switzerland)
• Promega Corporation (US)
• PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany)
• MagBio Genomics (US)
Research Coverage:
This report provides a detailed picture of the cell isolation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, cell source, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioreactors market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:
• Analysis of key drivers (Increasing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements), restraints (Ethical & safety issues related to embryonic stem cell isolation, high cost of cell-based research), opportunities (Growth opportunities in emerging markets) and challenges (Obstacles to develop cell therapies) influencing the growth of cell isolation market.
• Product Development/Innovation: Detailed insights on newly launched products, and technological assessment of the cell isolation market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the cell isolation market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players in the cell isolation market. The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（耐久財）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（instruments）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

細胞単離/細胞分離市場：製品（消耗品、器具）、細胞タイプ（ヒト細胞、動物細胞）、細胞源（骨髄、脂肪組織）、技術（遠心分離ベース）、用途、エンドユーザー（製薬）-2028年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（耐久財）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（instruments）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?